Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Deferitazole Formulations in Healthy Adults
NCT02065401Phase 1Withdrawn
- Sponsor
- Takeda
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of deferitazole in iron overload (3 arms), sponsored by Takeda. Primary endpoints: Area Under the Plasma Concentration-time Curve and Maximum Plasma Concentration. Planned start Feb 2014; status: withdrawn.
02
Drugs
deferitazole
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT02065401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065401.